Evaluation of changes in left ventricular structure and function in hypertensive patients with coronary artery

Yanhong Meng1, Ling Zong2, Ziteng Zhang2

  • 1Department of Ultrasound, The Affiliated Hospital of Jining Medical University, Jining, Shandong 272029, P.R. China.

Insights

Percutaneous coronary intervention (PCI) improved left ventricular function and synchrony in hypertensive patients with coronary artery disease. Real-time 3D echocardiography effectively tracked these positive changes post-PCI.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Hypertension Research

Background:

  • Hypertension and coronary artery disease (CAD) often coexist, impacting left ventricular (LV) function.
  • Percutaneous coronary intervention (PCI) is a common treatment for CAD, but its effect on LV structure and function in hypertensive patients requires detailed evaluation.

Purpose of the Study:

  • To assess changes in LV structure and function in hypertensive patients with CAD before and after PCI.
  • To evaluate the utility of real-time three-dimensional echocardiography (RT3DE) in monitoring these changes.

Main Methods:

  • A study involving 280 hypertensive patients with CAD undergoing PCI and 120 controls.
  • RT3DE was used to analyze LV volumes, ejection fraction (EF), and systolic synchrony indices (e.g., Tmsv-16SD) before and at 3 and 9 months after PCI.
  • All patients received standard medical therapy.

Main Results:

  • No significant baseline differences in LV end-diastolic volume, LV end-systolic volume (LVESV), or EF between groups.
  • Post-PCI, the PCI group showed significantly decreased LVESV and increased EF at 3 and 9 months (P<0.05).
  • Systolic synchrony parameters (Tmsv-16SD, Tmsv-16Dif, etc.) significantly improved in the PCI group post-treatment (P<0.05).

Conclusions:

  • PCI leads to significant improvements in LV systolic function and synchrony in hypertensive patients with CAD.
  • RT3DE is an accurate and real-time tool for evaluating prognostic parameters in these patients post-PCI.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
553
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
303
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
424
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
736
Structural Protein Function01:56

Structural Protein Function

Structural proteins are a category of proteins responsible for functions ranging from cell shape and movement to providing support to major structures such as bones, cartilage, hair, and muscles. This group includes proteins such as collagen, actin, myosin, and keratin.
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity.  In bones and teeth, it mineralizes to...
30.1K